Anda Pharmaceuticals Inc
United Arab Emirates
Mr. Philippe Archinard is Director of Biomerieux SA since June 10, 2010. He was previously Director - Representative of T.S.G.H. at the Company from April 16, 2004 until June 10, 2010. Mr. Archinard graduated from the Harvard Business School (Harvard University). He was Managing Director of Innogenetics from 2000 to 2003. He is Member of the Audit Committee and the Innovation and Technological Breakthroughs Committee at the Company and Director of the Immunotherapy division of Institut Merieux. He has held several other posts, including Chief Executive Officer of TSGH, Director of Erytech Pharma and Vice Chairman of BioAster, among others.